Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | PIM1 | P11309 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | METAP2 | P50579 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.42 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MC4R | P32245 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | MC3R | P41968 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL78566 | 1.00 | NISCH (0.50) | NISCHHSP90AA1CYP1A2PIM1CYP2D6 | |
| SCHEMBL29598957 | 1.00 | NISCH (0.50) | NISCHHSP90AA1CYP1A2PIM1CYP2D6 | |
| SCHEMBL9794662 | 0.97 | NISCH (0.48) | NISCHHSP90AA1CYP1A2PIM1CYP2D6 | |
| SCHEMBL31372462 | 0.97 | NISCH (0.48) | NISCHHSP90AA1CYP1A2PIM1CYP2D6 | |
| SCHEMBL14053846 | 0.97 | NISCH (0.48) | NISCHHSP90AA1CYP1A2PIM1CYP2D6 | |
| Hydrochloric Acid SCHEMBL3640139 | 0.97 | NISCH (0.48) | NISCHHSP90AA1CYP1A2PIM1CYP2D6 | |
| Hydrochloric Acid SCHEMBL30272980 | 0.94 | NISCH (0.46) | NISCHHSP90AA1CYP1A2PIM1CYP2D6 | |
| SCHEMBL5321481 | 0.88 | NISCH (0.43) | NISCHHSP90AA1CYP1A2PIM1CYP2D6 | |
| Bicarbonate SCHEMBL31484615 | 0.86 | HCAR2 (0.56) | NISCHHSP90AA1CYP1A2PIM1METAP2 | |
| SCHEMBL29713632 | 0.86 | NISCH (0.42) | NISCHHSP90AA1CYP1A2PIM1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120081719-A | Method for promoting exchange of aromatic ring system hydrogen and deuterium through hydrothermal reaction | 北京高压科学研究中心 | 2025-06-03 | — | — | CN | claimed |
| CN-120060869-A | Electrocatalytic synthesis method of aryl sulfone compound | 平顶山学院 | 2025-05-30 | — | — | CN | claimed |
| CN-113943314-B | For semiconductor manufacture is a photoresist of (a) | 台湾积体电路制造股份有限公司 | 2025-05-09 | — | — | CN | claimed |
| CN-119775215-A | Spin-control-induced CO2 reduction catalytic material and preparation and application methods thereof | 常州大学 | 2025-04-08 | — | — | CN | claimed |
| US-20240342161-A1 | BISBENZYLISOQUINOLINES AS CONDITIONING AGENTS FOR IMMUNE THERAPY | Escend Pharmaceuticals, Inc. | 2024-10-17 | — | — | US | claimed |
| CN-116676603-A | Electrochemical synthesis method of 2,2' -bipyrazine | 济南悟通生物科技有限公司 | 2023-09-01 | — | — | CN | claimed |
| CN-116096127-A | Laminated light-emitting field effect transistor and preparation method and application thereof | 中国科学院化学研究所 | 2023-05-09 | — | — | CN | claimed |
| US-12522598-B2 | 3-(2-(heteroaryl)-pyridin-4-yl)-5-(trifluoromethyl)-1,2,4-oxadiazole derivatives as HDAC6 inhibitors | ORYZON GENOMICS SA (ES) | 2026-01-13 | — | — | US | disclosed |
| CN-119775215-B | Spin-control-induced CO2 reduction catalytic material and preparation and application methods thereof | 常州大学 | 2025-10-10 | — | — | CN | disclosed |
| US-20250213724-A1 | RNA CONTAINING COMPOSITION FOR TREATMENT OF TUMOR DISEASES | CureVac SE (DE) | 2025-07-03 | — | — | US | disclosed |
| CN-120081719-A | Method for promoting exchange of aromatic ring system hydrogen and deuterium through hydrothermal reaction | 北京高压科学研究中心 | 2025-06-03 | — | — | CN | disclosed |
| CN-120060869-A | Electrocatalytic synthesis method of aryl sulfone compound | 平顶山学院 | 2025-05-30 | — | — | CN | disclosed |
| CN-113943314-B | For semiconductor manufacture is a photoresist of (a) | 台湾积体电路制造股份有限公司 | 2025-05-09 | — | — | CN | disclosed |
| US-20220298156-A1 | 3-(2-(HETEROARYL)-PYRIDIN-4-YL)-5-(TRIFLUOROMETHYL)-1,2,4-OXADIAZOLE DERIVATIVES AS HDAC6 INHIBITORS | ORYZON GENOMICS SA (ES) | 2022-09-22 | — | — | US | disclosed |
| EP-4048074-A1 | BIOACTIVE COMPOSITION FOR KILLING CELLS | AgXX Intellectual Property Holding GmbH (DE) | 2022-08-31 | — | — | EP | disclosed |
| US-20220259240-A1 | PROCESS FOR THE PREPARATION OF RUTHENIUM COMPLEXES | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2022-08-18 | — | — | US | disclosed |
| EP-4013764-A1 | PROCESS FOR THE PREPARATION OF RUTHENIUM COMPLEXES | Johnson Matthey Public Limited Company (GB) | 2022-06-22 | — | — | EP | disclosed |
| WO-2022096751-A1 | METHODS FOR DETECTION OF NUCLEOTIDE MODIFICATION | BLUECAT IP LIMITED (GB) | 2022-05-12 | — | — | WO | disclosed |
| EP-3980018-A1 | 4-SUBSTITUTED PYRANO[3,4,B]PYRAZINE KAPPA AGONISTS FOR TREATING DRUG DEPENDENCY | The Rockefeller University (US) | 2022-04-13 | — | — | EP | disclosed |
| WO-2022053718-A1 | METHOD FOR LABELING NUCLEIC ACID | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2022-03-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250213724-A1 | RNA CONTAINING COMPOSITION FOR TREATMENT OF TUMOR DISEASES | RNASE1, RNMT, TRDMT1 | NISCH 4798/4885HSP90AA1 924/4885CYP1A2 4808/4885 |
| US-20240342161-A1 | BISBENZYLISOQUINOLINES AS CONDITIONING AGENTS FOR IMMUNE THERAPY | NFATC1, CTNNB1, CAMK1D | NISCH 4739/4885HSP90AA1 1507/4885CYP1A2 4625/4885 |
| US-20220298156-A1 | 3-(2-(HETEROARYL)-PYRIDIN-4-YL)-5-(TRIFLUOROMETHYL)-1,2,4-OXADIAZOLE DERIVATIVES AS HDAC6 INHIBITORS | HDAC6, HDAC1, HDAC3 | NISCH 4807/4885HSP90AA1 194/4885CYP1A2 3097/4885 |
| US-20220259240-A1 | PROCESS FOR THE PREPARATION OF RUTHENIUM COMPLEXES | RUVBL1, RUVBL2, RPP30 | NISCH 2831/4885HSP90AA1 3676/4885CYP1A2 915/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.